Skip to content

Glucoplus, Inc.

Country not established

Devices
1

What Glucoplus, Inc. makes

Glucoplus, Inc. manufactures the GlucoPlus Blood Glucose Monitoring System, a device designed for measuring blood glucose levels in patients.

The company’s portfolio is regulated under FDA’s Class II device classification, with the GlucoPlus system authorised via the 510(k) pathway. The manufacturer is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

Frequently asked questions

How many devices does Glucoplus, Inc. have in the registry?

The registry currently lists 1 device for Glucoplus, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Glucoplus, Inc.'s devices?

Among its 1 most recently registered device, Glucoplus, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Glucoplus, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Glucoplus, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Glucoplus, Inc. in the registry?

The most recently registered devices listed for Glucoplus, Inc. include GLUCOPLUS BLOOD GLUCOSE MONITORING SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.